Exencial Wealth Advisors LLC Has $6.95 Million Stock Position in The Cooper Companies, Inc. $COO

Key Points

• Exencial Wealth Advisors LLC reduced its stake in The Cooper Companies by 4.4% in Q2, holding 97,671 shares valued at approximately $6.95 million.
• The Cooper Companies recently announced a $2 billion stock buyback program, allowing the company to repurchase up to 15.4% of its shares, suggesting management believes its stock is undervalued.
• For its latest quarter, Cooper Companies reported $1.10 earnings per share, slightly exceeding analysts' expectations with a revenue of $1.06 billion.

Exencial Wealth Advisors LLC trimmed its position in The Cooper Companies, Inc. (NASDAQ:COO - Free Report) by 4.4% in the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 97,671 shares of the medical device company's stock after selling 4,516 shares during the quarter. Exencial Wealth Advisors LLC's holdings in Cooper Companies were worth $6,950,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in COO. Exchange Traded Concepts LLC increased its position in Cooper Companies by 16.3% in the first quarter. Exchange Traded Concepts LLC now owns 1,502 shares of the medical device company's stock worth $127,000 after purchasing an additional 210 shares during the period. State of Alaska Department of Revenue grew its position in shares of Cooper Companies by 3.0% during the 1st quarter. State of Alaska Department of Revenue now owns 23,390 shares of the medical device company's stock worth $1,972,000 after buying an additional 680 shares during the period. Kentucky Retirement Systems Insurance Trust Fund acquired a new position in shares of Cooper Companies during the 1st quarter worth about $479,000. Asset Management One Co. Ltd. grew its position in shares of Cooper Companies by 15.2% during the 1st quarter. Asset Management One Co. Ltd. now owns 85,567 shares of the medical device company's stock worth $7,218,000 after buying an additional 11,320 shares during the period. Finally, Lecap Asset Management Ltd. grew its position in shares of Cooper Companies by 72.8% during the 1st quarter. Lecap Asset Management Ltd. now owns 20,662 shares of the medical device company's stock worth $1,743,000 after buying an additional 8,707 shares during the period. 24.39% of the stock is currently owned by institutional investors and hedge funds.

Cooper Companies Trading Up 0.0%

Shares of Cooper Companies stock opened at $75.00 on Wednesday. The Cooper Companies, Inc. has a 12-month low of $61.78 and a 12-month high of $109.04. The stock has a market cap of $14.91 billion, a P/E ratio of 36.95, a P/E/G ratio of 1.97 and a beta of 1.02. The company has a quick ratio of 1.24, a current ratio of 2.12 and a debt-to-equity ratio of 0.29. The business's 50 day moving average is $69.64 and its 200-day moving average is $73.21.

Cooper Companies (NASDAQ:COO - Get Free Report) last announced its quarterly earnings data on Wednesday, August 27th. The medical device company reported $1.10 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.07 by $0.03. The company had revenue of $1.06 billion for the quarter, compared to analysts' expectations of $1.06 billion. Cooper Companies had a return on equity of 9.82% and a net margin of 10.08%.The business's revenue was up 5.7% compared to the same quarter last year. During the same quarter in the prior year, the business posted $0.96 EPS. Cooper Companies has set its Q4 2025 guidance at 1.100-1.140 EPS. FY 2025 guidance at 4.080-4.120 EPS. Equities research analysts predict that The Cooper Companies, Inc. will post 3.98 earnings per share for the current fiscal year.

Cooper Companies announced that its Board of Directors has authorized a stock repurchase program on Wednesday, September 17th that allows the company to buyback $2.00 billion in shares. This buyback authorization allows the medical device company to purchase up to 15.4% of its stock through open market purchases. Stock buyback programs are often an indication that the company's leadership believes its shares are undervalued.

Insider Transactions at Cooper Companies

In related news, EVP Brian G. Andrews bought 1,525 shares of Cooper Companies stock in a transaction dated Tuesday, September 2nd. The shares were bought at an average cost of $65.68 per share, with a total value of $100,162.00. Following the acquisition, the executive vice president owned 22,191 shares in the company, valued at $1,457,504.88. This trade represents a 7.38% increase in their position. The transaction was disclosed in a document filed with the SEC, which is available through this link. Also, COO Gerard H. Warner III bought 1,450 shares of Cooper Companies stock in a transaction dated Friday, September 5th. The shares were bought at an average cost of $69.23 per share, for a total transaction of $100,383.50. Following the completion of the acquisition, the chief operating officer owned 18,319 shares in the company, valued at $1,268,224.37. This represents a 8.60% increase in their position. The disclosure for this purchase can be found here. Over the last quarter, insiders acquired 17,975 shares of company stock worth $1,216,346. 1.98% of the stock is currently owned by company insiders.

Analyst Ratings Changes

Several equities analysts have recently issued reports on the company. The Goldman Sachs Group set a $64.00 target price on Cooper Companies and gave the stock a "sell" rating in a research report on Wednesday, October 1st. Mizuho cut their price objective on Cooper Companies from $105.00 to $90.00 and set an "outperform" rating on the stock in a report on Wednesday, July 16th. Wells Fargo & Company decreased their price objective on Cooper Companies from $93.00 to $72.00 and set an "overweight" rating for the company in a research report on Thursday, August 28th. Robert W. Baird decreased their price objective on Cooper Companies from $97.00 to $85.00 and set an "outperform" rating for the company in a research report on Thursday, August 28th. Finally, Barclays initiated coverage on Cooper Companies in a research report on Monday, October 13th. They issued an "overweight" rating and a $85.00 price objective for the company. One analyst has rated the stock with a Strong Buy rating, ten have given a Buy rating, three have issued a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and a consensus price target of $84.77.

Cooper Companies Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.

Want to see what other hedge funds are holding COO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Cooper Companies, Inc. (NASDAQ:COO - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.